CoChat

The gut microbiome and metabolites are altered and interrelated in patients with functional constipation

Open access
Li, Yan-qiu, Yan, Xiang-yun, Xiao, Xian-jun, Ma, Pei-tao, Wang, Si-qi, Liu, Hui-lin, Zhang, Wei, Chen, Min, Yao, Jun-peng, Li, Ying · 2023 · Frontiers in Microbiology

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Introduction: Gut microbiota and metabolites have been identified to contribute to the pathogenesis of functional constipation (FC); however, the underlying mechanism(s) have not been elucidated, and the relationship between the gut microbiota and metabolites in FC has received limited attention in the literature. Methods: 16S rDNA sequencing and non-targeted metabolomic detection based on liquid chromatography-mass spectrometry (LC–MS/MS) technologies were combined to analyze the altered gut microbiome and metabolic profile of fecal samples from FC patients and healthy individuals (healthy control; HC). Results: The richness and diversity of gut microbiota significantly (p < 0.01) increased in FC patients. Compared to the HC group, 18 genera, including Intestinibacter, Klebsiella, and Akkermansia, exhibited statistically significant changes (p < 0.05). Metabolic analysis showed that metabolic profiles were also markedly altered with 79 metabolites, such as (-)-caryophyllene oxide, chenodeoxycholic acid, and biliverdin, indicating significant inter-group differences (p < 0.05). Besides, the primary bile acid biosynthesis, as well as the metabolic profile of porphyrin and chlorophyll, were the most dominant enriched pathways (FDR < 0.01), in which chenodeoxycholic acid and biliverdin were significantly enriched, respectively. Correlation analysis demonstrated a strong relationship between 10 genera and 19 metabolites (r > 0.6, FDR < 0.05), and notably, Intestinibacter showed a negative correlation with biliverdin (FDR < 0.001), which highlighted the interplay of the gut microbiota and metabolites in the pathogenesis of FC. Conclusion: Our research describes the characteristics of the gut microbiota and metabolic profiles and the correlation between the gut microbiota and metabolites in FC patients. This may contribute to the understanding of the underlying mechanisms involved in FC pathogenesis and may provide novel insights into therapeutic interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2023.1320567

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 (A) Rarefaction curve. Each curve represents a sample. The nearly smooth curves indicate that sequencing samples are adequate. (B) Inter-group differences of alpha diversity indices, including the Chao1 index, Shannon index, and Simpson index. ***p < 0.001, **p < 0.01. (C) PCoA plot showing the difference in the fecal microbial composition between the two groups. The abscissa and ordinate represent the two main components with the greatest contribution to explaining the inter-group difference. (D) Relative abundance of the microbiome at the phylum level of the two groups. (E) Differential microbiome of the FC and HC groups at the genus levels.
Figure 1 (A) Rarefaction curve. Each curve represents a sample. The nearly smooth curves indicate that sequencing samples are adequate. (B) Inter-group differences of alpha diversity indices, including the Chao1 index, Shannon index, and Simpson index. ***p < 0.001, **p < 0.01. (C) PCoA plot showing the difference in the fecal microbial composition between the two groups. The abscissa and ordinate represent the two main components with the greatest contribution to explaining the inter-group difference. (D) Relative abundance of the microbiome at the phylum level of the two groups. (E) Differential microbiome of the FC and HC groups at the genus levels.CC BY · PubMed Central
Figure 2 (A) LDA score diagram and the significantly differential genera. The color represents groups, and the length of the histogram represents the LDA score. The higher the score, the more significant difference in the differential microbiome. (B) Phylogenetic tree in the cladogram of differential taxa. Different colors represent different groups and different microbiota at different levels. (C) Pairwise comparisons of the gut genera with Spearman's correlation coefficient and the correlation between genera and clinical parameters with the Mantel test. The edge width represents Spearman's r-value for the corresponding distance correlations, and the color represents the statistical significance. Blue represents a positive correlation, and red represents a negative correlation. (D) PICRUST result indicating the potential function of differential microbiota. Red represents the HC group, and blue represents the FC group.
Figure 2 (A) LDA score diagram and the significantly differential genera. The color represents groups, and the length of the histogram represents the LDA score. The higher the score, the more significant difference in the differential microbiome. (B) Phylogenetic tree in the cladogram of differential taxa. Different colors represent different groups and different microbiota at different levels. (C) Pairwise comparisons of the gut genera with Spearman's correlation coefficient and the correlation between genera and clinical parameters with the Mantel test. The edge width represents Spearman's r-value for the corresponding distance correlations, and the color represents the statistical significance. Blue represents a positive correlation, and red represents a negative correlation. (D) PICRUST result indicating the potential function of differential microbiota. Red represents the HC group, and blue represents the FC group.CC BY · PubMed Central
Figure 3 (A, B) OPLS-DA score plots in positive and negative ion models, respectively. The abscissa represents the difference between groups, and the ordinate represents the difference within groups. (C, D) Validation models through 200 permutation tests in positive and negative ion models, respectively. R2 and Q2 are the intercept values of the fitted lines on the ordinate, respectively, and represent the reliability and overfitting degree of the model. (E, F) Volcano plots in positive and negative models, respectively, indicate the discrimination of fecal metabolites between the two groups. The ordinate shows the -log10 (p-value), and the abscissa is the log2 (fold change) value. The screening threshold of significantly differential metabolites was fold change > 2, VIP value > 1.5, and p-value < 0.05 or fold change < 0.5, VIP value > 1.5, and p < 0.05. Every dot represents a kind of metabolite, and the blue ones represent the significantly down-regulated metabolites, while the red dots represent the significantly up-regulated metabolites. The gray dots represent the metabolites that have no significant difference between the two groups.
Figure 3 (A, B) OPLS-DA score plots in positive and negative ion models, respectively. The abscissa represents the difference between groups, and the ordinate represents the difference within groups. (C, D) Validation models through 200 permutation tests in positive and negative ion models, respectively. R2 and Q2 are the intercept values of the fitted lines on the ordinate, respectively, and represent the reliability and overfitting degree of the model. (E, F) Volcano plots in positive and negative models, respectively, indicate the discrimination of fecal metabolites between the two groups. The ordinate shows the -log10 (p-value), and the abscissa is the log2 (fold change) value. The screening threshold of significantly differential metabolites was fold change > 2, VIP value > 1.5, and p-value < 0.05 or fold change < 0.5, VIP value > 1.5, and p < 0.05. Every dot represents a kind of metabolite, and the blue ones represent the significantly down-regulated metabolites, while the red dots represent the significantly up-regulated metabolites. The gray dots represent the metabolites that have no significant difference between the two groups.CC BY · PubMed Central
Figure 4 (A) Pathway enrichment bar plot of differential metabolites. The abscissa represents enrichment radio, and the ordinate represents enrichment pathways. (B) Seven differential metabolites were enriched in the pathways. ***p < 0.001, **p < 0.01, *p < 0.05.
Figure 4 (A) Pathway enrichment bar plot of differential metabolites. The abscissa represents enrichment radio, and the ordinate represents enrichment pathways. (B) Seven differential metabolites were enriched in the pathways. ***p < 0.001, **p < 0.01, *p < 0.05.CC BY · PubMed Central
Figure 5 (A) Correlations between differential genera and differential metabolites. Red represents a positive correlation, and blue represents a negative correlation. The size of each dot represents the significant degree of correlation. (B) Correlation network graph of the differential genera and metabolites with Spearman's r-value > 0.6. Blue dots represent the differential genera, and red dots represent differential metabolites. Pink lines represent positive correlations, while gray lines represent negative correlations. The width of the line is proportional to the absolute value of the r-value. (C) ROC curves of the combination of the differential genera and metabolites with Spearman's r-value > 0.6.
Figure 5 (A) Correlations between differential genera and differential metabolites. Red represents a positive correlation, and blue represents a negative correlation. The size of each dot represents the significant degree of correlation. (B) Correlation network graph of the differential genera and metabolites with Spearman's r-value > 0.6. Blue dots represent the differential genera, and red dots represent differential metabolites. Pink lines represent positive correlations, while gray lines represent negative correlations. The width of the line is proportional to the absolute value of the r-value. (C) ROC curves of the combination of the differential genera and metabolites with Spearman's r-value > 0.6.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 22

Metadata

Authors
Li, Y.-Q., Yan, X.-Y., Xiao, X.-J., Ma, P.-T., Wang, S.-Q., Liu, H.-L., Zhang, W., Chen, M., Yao, J.-P., & Li, Y.
Affiliations
Chengdu University of Traditional Chinese Medicine (CN)
Corresponding author
Li, Ying
Venue
Frontiers in Microbiology
Published
2023-12-06
Volume
14
Pages
1320567-1320567
ISSN
1664-302X (ISSN-L)
OpenAlex
W4389393171
Cited by
22
References
48
Citations by year
2026: 11 · 2025: 4 · 2024: 7
FWCI
1.95
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Microbiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (82074554)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
functional constipation, gut microbiota, fecal metabolites, biliverdin, fecal microbiota, metabolite profiling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The gut microbiome and metabolites are altered and interrelated in patients with functional constipation. https://app.cochat.ai/papers/10.3389/fmicb.2023.1320567
The paper
Li, Y.-Q., Yan, X.-Y., Xiao, X.-J., Ma, P.-T., Wang, S.-Q., Liu, H.-L., Zhang, W., Chen, M., Yao, J.-P., & Li, Y. (2023). The gut microbiome and metabolites are altered and interrelated in patients with functional constipation. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2023.1320567

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.